# Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
Canonical URL: https://biopharmsignal.com/news/AVAH/aveanna-healthcare-holdings-announces-first-quarter-financial-results-and-revised-2026-guidance
Ticker: AVAH
Company: Aveanna Healthcare
Source: Aveanna Healthcare
Published: 2026-05-14 11:00 EST
Original Source URL: https://ir.aveanna.com
## Summary

First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year period First Quarter Net income was $41.7 million compared to $5.2 million for the prior year period Adjusted EBITDA for Q1 2026 was $84.4 million, a 25.2% increase over the prior year period Increased Full Year 2026

## Article Body
First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year period First Quarter Net income was $41.7 million compared to $5.2 million for the prior year period Adjusted EBITDA for Q1 2026 was $84.4 million, a 25.2% increase over the prior year period Increased Full Year 2026
## Recent Company News
- 2026-06-02 11:30 EST — [Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance](https://biopharmsignal.com/news/AVAH/aveanna-healthcare-holdings-completes-acquisition-of-family-first-homecare-and-updates-full-year-2026-guidance) — Source: Aveanna Healthcare
- 2026-05-28 12:00 EST — [Aveanna Healthcare Announces Successful Debt Repricing](https://biopharmsignal.com/news/AVAH/aveanna-healthcare-announces-successful-debt-repricing) — Source: Aveanna Healthcare
- 2026-05-14 11:00 EST — [Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance](https://biopharmsignal.com/news/AVAH/aveanna-healthcare-holdings-announces-first-quarter-financial-results-and-revised-2026-guidance) — Source: Aveanna Healthcare
- 2026-05-12 11:30 EST — [Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference](https://biopharmsignal.com/news/AVAH/aveanna-to-participate-at-the-william-blair-46th-annual-growth-stock-conference) — Source: Aveanna Healthcare
- 2026-04-28 11:30 EST — [Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference](https://biopharmsignal.com/news/AVAH/aveanna-to-participate-at-the-barclays-30th-annual-leveraged-finance-conference) — Source: Aveanna Healthcare
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)